BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12535843)

  • 1. Improved method for measurement of human plasma xanthine oxidoreductase activity.
    Liu X; Lin WM; Yan XH; Chen XH; Hoidal JR; Xu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 785(1):101-14. PubMed ID: 12535843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry.
    Murase T; Nampei M; Oka M; Ashizawa N; Matsumoto K; Miyachi A; Nakamura T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():189-197. PubMed ID: 26673227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent association of plasma xanthine oxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry.
    Kurajoh M; Fukumoto S; Emoto M; Murase T; Nakamura T; Ishihara T; Go H; Yamamoto K; Nakatani S; Tsuda A; Yamada S; Morioka T; Mori K; Imanishi Y; Inaba M
    Clin Chem Lab Med; 2020 Apr; 58(5):780-786. PubMed ID: 31085741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS.
    Murase T; Nampei M; Oka M; Miyachi A; Nakamura T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():51-58. PubMed ID: 27816314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of xanthine oxidoreductase forms: influence of reaction conditions.
    Martí R; Varela E; Pascual C; Segura RM
    Clin Chim Acta; 2001 Jan; 303(1-2):117-25. PubMed ID: 11163031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.
    Washio KW; Kusunoki Y; Murase T; Nakamura T; Osugi K; Ohigashi M; Sukenaga T; Ochi F; Matsuo T; Katsuno T; Moriwaki Y; Yamamoto T; Namba M; Koyama H
    Metabolism; 2017 May; 70():51-56. PubMed ID: 28403945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive assay for xanthine oxidoreductase activity using a combination of [(13) C2 ,(15) N2 ]xanthine and liquid chromatography/triple quadrupole mass spectrometry.
    Murase T; Oka M; Nampei M; Miyachi A; Nakamura T
    J Labelled Comp Radiopharm; 2016 May; 59(5):214-20. PubMed ID: 27006202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine oxidoreductase reference values in platelet-poor plasma and platelets in healthy volunteers.
    Cecerska-Heryć E; Jesionowska A; Klaudyna S; Katarzyna S; Dominika M; Dominika P; Marta U; Dołęgowska B
    Oxid Med Cell Longev; 2015; 2015():341926. PubMed ID: 25688294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Nasako Y; Hiroishi K; Higashino K
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):395-400. PubMed ID: 8811453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.
    Fujimura Y; Yamauchi Y; Murase T; Nakamura T; Fujita SI; Fujisaka T; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
    PLoS One; 2017; 12(8):e0182699. PubMed ID: 28797123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid.
    Furuhashi M; Mori K; Tanaka M; Maeda T; Matsumoto M; Murase T; Nakamura T; Koyama M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
    Endocr J; 2018 Nov; 65(11):1083-1092. PubMed ID: 30068899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of allantoin and adenosine in human urine using liquid chromatography - UV detection.
    Andries A; De Rechter S; Janssens P; Mekahli D; Van Schepdael A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():201-207. PubMed ID: 30176509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of guanine, uric acid, hypoxanthine and xanthine in human plasma by reversed-phase high-performance liquid chromatography with amperometric detection.
    Liu Z; Li T; Wang E
    Analyst; 1995 Aug; 120(8):2181-4. PubMed ID: 7677251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases.
    Sato K; Naganuma A; Nagashima T; Arai Y; Mikami Y; Nakajima Y; Kanayama Y; Murakami T; Uehara S; Uehara D; Yamazaki Y; Murase T; Nakamura T; Uraoka T
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
    Otaki Y; Watanabe T; Kinoshita D; Yokoyama M; Takahashi T; Toshima T; Sugai T; Murase T; Nakamura T; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Int J Cardiol; 2017 Feb; 228():151-157. PubMed ID: 27865177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry.
    Kurajoh M; Fukumoto S; Akari S; Murase T; Nakamura T; Ihara Y; Imai T; Nagata Y; Morioka T; Mori K; Imanishi Y; Watanabe T; Emoto M
    Int J Cardiol Heart Vasc; 2023 Oct; 48():101264. PubMed ID: 37680549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens.
    Carro MD; Falkenstein E; Radke WJ; Klandorf H
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):12-7. PubMed ID: 19654053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthine oxidoreductase activity is correlated with hepatic steatosis.
    Yagi C; Kusunoki Y; Tsunoda T; Murase T; Nakamura T; Osugi K; Ohigashi M; Morimoto A; Miyoshi A; Kakutani-Hatayama M; Kosaka-Hamamoto K; Kadoya M; Konishi K; Shoji T; Koyama H
    Sci Rep; 2022 Jul; 12(1):12282. PubMed ID: 35854080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of uric acid, xanthine and hypoxanthine in human serum by HPLC for pharmacodynamic studies.
    Cooper N; Khosravan R; Erdmann C; Fiene J; Lee JW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):1-10. PubMed ID: 16631418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase.
    O'Byrne S; Shirodaria C; Millar T; Stevens C; Blake D; Benjamin N
    J Pharmacol Exp Ther; 2000 Jan; 292(1):326-30. PubMed ID: 10604966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.